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Background: Acute respiratory distress (ARD) is a relatively frequent occurrence in patients
suffering from central nervous system disorders (CNSD) and moderate to severe mental retar-
dation. Whenever conventional therapy is little effective, noninvasive mechanical ventilation
(NIV) is the additional treatment in patients with diseases of the peripheral nervous system.
However, NIV is traditionally little employed in the acute phase in patients suffering from
CNSD. In the latter, either conventional therapy is maintained or invasive mechanical ventila-
tion is instituted if the patient’s condition worsens severely. To challenge the traditional view,
we conducted the study to prove that NIV is both applicable and effective in the treatment of
ARD also in children with moderate to severe mental retardation.
Methods: We studied 44 children with ARD secondary to pneumonia and CNSD causing moder-
ate to severe mental retardation. The children were divided in two groups. One group received
conventional therapy and NIV, the other conventional therapy only, before being advanced to
invasive ventilator support when nonresponding. On admission to hospital and one hour
following admission we registered pH, PaCO2, PaO2, A e a DO2 and the PaO2/FiO2 ratio.
The mean hospital stay was also recorded.
Results: After one hour on NIV PaO2 and pH increased, PaCO2 decreased, A e a DO2 and PaO2/
FiO2 ratio improved. No changes in the above parameters were observed in children on conven-
tional therapy only. Hospital stay was shorter when NIV was instituted.
Conclusions: NIV is both applicable and beneficial in stabilizing blood gases, respiratory and car-
diovascular parameters also in children with CNSD. Moreover its use shortens the hospital stay.
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children with CNSD and tachypnea, dyspnea, retractions,Children with central nervous system disorders (CNSD) are
at increased risk of acute respiratory distress because they
often have compromised pulmonary function and ability to
handle secretions, which may, in case of viral infection,
result in pneumonia [1]. According to Hollins [2] pneumonia
accounts for 77% of deaths of patients admitted to hospital
for neurological problems. Recurrent aspiration, ineffec-
tive cough reflex, reduced or ineffective mucociliary
clearance [3,4] are predisposing factors. Other predisposing
factors are deformities of the rib cage such as kyphosco-
liosis that reduces the vital capacity [5], or the low sensi-
tivity of central and peripheral chemoreceptors as found in
Arnold Chiari disease [6]. Diagnosing acute respiratory
distress early enough that noninvasive support would be
feasible can be made more challenging if a child’s degree of
cognitive impairment severely limits his or her ability to
communicate with care providers [7,8]. When mechanical
ventilatory support is required, clinicians have traditionally
opted to offer endotracheal intubation because of a
perceived inability of children with CNSD to tolerate well
noninvasive ventilation. Invasive mechanical ventilation
has a number of drawbacks and side effects. It requires
deep sedation [9,10], exposes to the risk of ventilator-
associated pneumonia, extends hospital stay [11e13], and
the child can end up ventilator dependent [14,15]. There-
fore in many centers invasive mechanical ventilation is
instituted only when there is reasonable expectancy that
the patient is weaned off the ventilator. As a consequence
many children affected by CNSD are denied ventilatory
support in case of acute respiratory distress and are treated
solely with antibiotics and oxygen delivered via an ordinary
device (face mask or nasal cannula). Taking such decisions
in an emergency department, weighing institution guide-
lines against parents’ expectations carries momentous
ethical implications [16e19].
There is substantial evidence that noninvasive ventila-
tion (NIV) is safe and effective in the treatment of acute
respiratory failure in adults [20] and in children [21].
Therefore, challenging the common attitude we have
tested the applicability and effectiveness of NIV in children
with CNSD and moderate to severe mental retardation,
admitted to a pediatric emergency department for acute
respiratory distress from pneumonia.Methods
This is a prospective nonrandomized nonblinded study.
The study protocol, approved by the ethic committee at
our institutions, conformed to the ethical guidelines of the
1975 Declaration of Helsinki as revised in 2000 [22].
Patients
We entered in the study 74 children with CNSD with mental
retardation regularly followed up at the unit of pediatric
neurology of the department of pediatrics of the teaching
hospital Vittorio Emanuele in Catania, admitted to the
pediatric emergency department, between May 2010 andJune 2012 for an episode of acute respiratory distress (i.e.
grunting, nasal flaring, apnea, altered mental status, pulse
oximetry measurement <90 on room air) according to
Bradely et al. [15] secondary to very severe pneumonia, as
defined by Scott et al. [23].
In nearly 80% of our patients the etiology of pneumonia
was viral. However we could not assert how many suffered
from concomitant aspiration pneumonia, that is often
associated to the infective form.Study protocol
On admission to the emergency department of pediatrics,
both parents of each child were informed of the availability
of NIV and of the traditional objections to its use in patients
with moderate to severe mental retardation. Informed
consent for the use of NIV was requested and if the option
was accepted the child entered the Intervention Group
(IG). Children of parents refusing consent to the use of NIV
formed the Control Group (CG), Fig. 1.
Causes of exclusion from the study were the presence
of: mono or bilateral pleural effusion; PaO2 >60 mmHg and
PaCO2 <45 mmHg. mild mental retardation according to
International Classification of Functioning Disability and
Health e Children & Youth (ICF-CY) [28]. The mental
retardation was evaluated on the basis of score for mental
retardation (code B117) and score for muscular tone (code
B7354) detectable from the medical record of the child. For
both tests a score greater than 2 was indicative of the
presence of a moderate or severe mental retardation.
Appropriateness of the diagnosis of the degree of mental
retardation was reassessed individually by two pediatric
neurologists by careful examination of patients’ charts.
The children of the control group received a conven-
tional treatment with: aerosol therapy with albuterol, i.v.
fluids in amounts adequate to maintain a neutral fluid
balance, and i.v. antibiotics according to the guidelines
suggested by Esposito et al. [24] and Bradley et al. [25].
Oxygen administration via facial mask was instituted, with
fraction of inspired oxygen (FiO2) adequate for the levels of
SaO2 (minimum concentration of oxygen that maintains
saturations between 88% and 92%) in accord with the
guidelines published by Mangera et al. [16].
The children in the intervention group were treated
with conventional therapy, as above described, plus non-
invasive positive pressure ventilation, with a Bi-Level
mode.
For NIV we use a positive inspiratory pressure between
10 and 14 mmHg and positive end-expiratory pressure be-
tween 4 and 6 mmHg. The backrest was lifted to an angle of
45, or the patient was put in a lateral decubitus if unable
to sustain a semirecumbent position. A full face mask of
adequate size was put in place and Bi-Level NIV started
according to British Thoracic Society guidelines [26,27].
Initially the facial mask was hold gently in place by hand
and then tightened with tight-fitting securing system when
tolerated. Hydrocolloid was used to prevent pressure sores
at the bridge of the nose and other points of pressure.
The alarm was set monitoring O2 saturation (alarm set for
SaO2 < 90%).
Figure 1 Phases of the study.
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and respiratory rate (RR) were started and blood gas ob-
tained for pH, partial pressure of oxygen (PaO2) and partial
pressure of carbon dioxide (PaCO2). Concomitantly the
alveolar-arterial oxygen gradient (A e a DO2) and the
PaO2/FiO2 ratio were also calculated.
A chest X-rays, taken immediately thereafter, was
assessed by two radiologists first independently and then in
comparison.
After one hour of treatment in both groups blood gas
analyses were repeated.
In the study, FiO2 was measured with an Oxygen
Analyzer (Oxicheck, Respironics, Philips).Objectives of the study
A preliminary consideration was given to the homogeneity
of the study group (IG) and controls (CG). The two groups
are compared for, age; sex; central nervous system disor-
ders; score of mental retardation (code B117) and score of
muscular tone (code B7354) of the ICF-CY; medications
(e.g. inhaled bronchodilators); history of recurrent pulmo-
nary infections with persistent cough, fever and dyspnea;
chest physiotherapy; previous episodes of acute respiratory
failure; episodes of pneumonia for year; X-ray findings on
admission.
Primary endpoint was to evaluate changes of PaO2,
PaCO2, pH, respiratory rate, heart rate, A e a DO2, and the
PaO2/FiO2 ratio:
- in the two groups between the time of admission and
after an hour of therapy- and between the two groups either at admission that
after an hour of therapy.
Secondary endpoint was the occurrence of complica-
tions possibly secondary to NIV, the number of children in
both groups that required the institution of invasive me-
chanical ventilation at some point, and the length of hos-
pital stay before recovery.
The length of hospital stay was measured by days spent
in the semi-intensive ward where the patient was hospi-
talized after acceptance in the emergency department
until the time of discharge or his transfer to the intensive
care unit in case it had been required endotracheal intu-
bation and mechanical ventilation.
Statistical analysis
For statistical analysis we relied on JMP 10 program for
Mac by SAS Institute. For all variables the approximation to
normal of the distribution of the population was tested
by KolmogoroveSmirnov One-Sample Test and statistics
for kurtosis and symmetry. Results were symmetrically
distributed and were therefore analyzed with the t test for
paired data. A p < 0.05 was considered significant.
Results
Between May 2010 and June 2012, 74 children suffering
from CNSD were seen in the emergency department
because of an acute episode of respiratory failure; of
these 44 were enrolled in the study and 30 were excluded
because they did not meet the inclusion criteria. Twenty-
Table 1 Patients’ characteristics of the two groups treated with (intervention group) or without (control group) non-invasive
ventilation.
Intervention group Control group p<
Males/females 10/12 13/9
Mean age years 7.18  2.63a 6.77  2.67a NS
Central nervous system disorders (CNSD) 10 SD 7 CM, 3 EE, and 2 L 9 SD 6 CM, 6 EE, and 1 L NS
Score for mental retardation (code B117) 3.32  0.48a 3.50  0.51a NS
Score for muscular tone (code B7354) 3.77  0.42a 3.95  0.21a NS
Inhaled bronchodilators prior to admission 22/22 20/22 NS
Chest physiotherapy 20/22 22/22 NS
Prior history of episode of acute respiratory failure 12/22 14/22 NS
Episodes of pneumonia for year 7.22  0.81a 7.09  0.75a NS
Chest radiography in ED 18 ULI; 4 BLI 18 ULI; 4 BLI NS
SD: spastic diplegia; CM: cerebral malformations; EE: epileptic encephalopathy nonrespondent to pharmacological treatment; L: leu-
kodystrophies; ULI: unilateral lung involvement; BLI: bilateral lung involvement.
a Mean  standard deviation.
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support and form the intervention group; the remaining 22
form the control group. As shown in Table 1, the inter-
vention and the control groups are fully comparable for
age; sex; CNSD; score of mental retardation (code B117)
and score of muscular tone (code B7354); medications
(e.g. inhaled bronchodilators); history of recurrent pul-
monary infections with persistent cough, fever and dys-
pnea; chest physiotherapy; previous episodes of acute
respiratory failure; episodes of pneumonia per year; X-ray
findings.
All had fever >38.5 C, dyspnea, nonproductive cough,
respiratory muscles strain, and cyanosis. At physical ex-
amination there were severe rales and wheezing.
Blood gases on admission (T0) were consistent with Type
2 respiratory distress in all (Table 2). At T0 there were no
statistically significant differences between groups for
PaCO2, PaO2, pH, A e a DO2 difference, PaO2/FiO2 ratio;
heart and respiratory rate (Tables 2 and 3).
After 1 h (T1), in the intervention group all parameters
under scrutiny improved significantly: PaCO2 was reducedTable 2 Blood gas (PaCO2, PaO2 and pH) and respiratory param
one hour (T1), in the groups treated with (intervention group e
Intervention group
T0 T1
PaCO2 mmHg 52.90  8.32 42.41 
PaO2 mmHg 52.73  6.62 64.18 
pH 7.37  0.06 7.41 
A e a DO2 mmHg 378  15.75 35 
PaO2/FiO2 mmHg 75  9.47 291 
Groups PaCO2 PaO2
p< p<
IG T0 vs CG T0 NS NS
IG T0 vs IG T1 0.0001 0.0001
CG T0 vs CG T1 NS NS
IG T1 vs CG T1 0.0001 0.0003(p < 0.0001); PaO2 increased (p < 0.0001); A e a DO2 was
reduced (p < 0.0001); PaO2/FiO2 ratio increased
(p < 0.0001). HR and RR were also significantly reduced
(p < 0.0001). On the contrary controls did not improve at
one hour (Tables 2 and 3); the only significant change was a
decrease of respiratory rate (p < 0.0003).
Overall the mean hospital stay was significantly shorter
in the intervention group (6.22  1.27 vs 11.63  2.17 days;
p < 0.0001; difference Z 5.41 Upper CL Dif 4.3187,
Lower CL Dif 6.50).
In two additional cases NIV had to be discontinued
because of poor patient and family compliance. None of the
patients on NIV required invasive mechanical ventilation at
any time, while three children in the control group went
into progressing desaturation not responding to conserva-
tive measures: two had to be started on invasive mechan-
ical ventilation; the parents of the third child refused
mechanical ventilation and the patient unfortunately died.
Three minor complications secondary to NIV were
observed: facial erythema in two children and bridge of the
nose ecchymosis in one.eters (A e a DO2 and PaO2/FiO2) on admission (T0) and after
IG) or without (control group e CG) non-invasive ventilation.
Control group
T0 T1
5.88 49.50  3.57 51.68  7.21
13.19 50.45  5.09 55.04  3.23
0.07 7.36  0.07 7.37  0.05
9.59 383  4.03 381  11.55
36.76 72  7.28 78  4.61
pH A e a DO2 PaO2/FiO2
p< p< p<
NS NS NS
0.02 0.0001 0.0001
NS NS NS
0.014 0.0001 0.0001
Table 3 Heart Rate (HR) and Respiratory Rate (RR) on admission (T0) and after one hour (T1), in the groups treated with
(intervention group e IG) or without (control group e CG) non-invasive ventilation.
Intervention group Control group
T0 T1 T0 T1
HR 157.32  25.61 101.09  15.18 159.14  26.74 132.36  23.86
RR 60.95  8.63 43.09  7.41 62.09  9.03 57.68  7.51
Groups HR RR
p< p<
IG T0 vs CG T0 NS NS
IG T0 vs IG T1 0.0001 0.0001
CG T0 vs CG T1 0.0003 NS
IG T1 vs CG T1 0.0001 0.0001
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Respiratory diseases are the most frequent and serious
comorbidities in patients with CNSD [29,30]. Recent
studies indicate that NIV is effective in treating episodes
of acute respiratory failure in children with diseases of
the peripheral nervous system [29,31,32], as NIV increases
the functional residual capacity, improves tissue oxygen-
ation, decreases left ventricular postload, and reduces
the respiratory muscle work [33]. Indications and man-
agement guidelines for NIV have also been published
[33,34]. However guidelines usually stress the difficulties
associated with the use of NIV in children with CNSD
[34e36]. In this study we treated acute respiratory
distress with NIV in a number of children with CNSD and
moderate to severe mental retardation. In all patients one
hour NIV treatment lead to significant improvement of all
monitored parameters: PaCO2, PaO2, pH, A e a DO2 dif-
ference, and PaO2/FiO2 ratio, while in the control group
no significant changes were observed. The second
parameter recording was set at one hour in accord with
the reports by several authors that NIV treatment for one
hour is sufficient to stabilize acute respiratory distress in
children [21,26].
Although conducted on a small cohort, our study, dem-
onstrates that NIV can be well tolerated also by children
with severe CNS disorders. We think that the poor state of
conscience of children with CNSD, further increased by
respiratory distress, not only is not an obstacle but may
even favor the use of NIV. Recently Scala supported the use
of NIV for treatment of acute respiratory failure in hyper-
capnic encephalopathy syndrome [37] as, just because of
the hypercapnic state, the patient is unlikely to resist the
ventilator. An additional consideration is that prompt
response to NIV as it is commonly observed [38] shortens
the time spent in hospital and speeds recovery.
No patients treated with NIV had to be advanced to
mechanical ventilation with endotracheal tube, while three
children in the control group required mechanical ventila-
tion, but only two families accepted it, while the third died
on conventional therapy. In our department the indication
to orotracheal intubation for mechanical ventilation is the
rapid increase of muscular effort during respiration and thesevere difficulty to maintain acceptable levels PaO2 e della
PaCO2.
The minor complications associated with NIV were
attributable to a selection error of the mask size. In all the
symptoms receded after we changed the mask to one more
appropriate in size.
Study limitations
As stated previously, the allocation of the patients to the
interventional or the control group was not randomized but
was determined by the free choice of the parents to grant
or refuse consent to treatment with NIV. Lack of randomi-
zation carries a risk of bias. And one cannot rule out a
difference in treatment at home prior to admission and
uneven distribution of preexisting clinical conditions.
However, as reported in Table 1, the two groups turned out
fully comparable. This can be due in part to the fact that all
children were regularly followed in the same rehabilitation
center of the same pediatric unit, and the outpatients
respiratory problems secondary to their neurological con-
dition are treated according with the very same protocol
based on the guidelines set by Wang et al. [39].
As previously stated, in our cohort of children with
neuromuscular diseases aspiration pneumonia is frequently
associated to infection, either viral or bacterial, and it can
be difficult to ascertain which one comes first.
In conclusion, NIV is safe and valuable (stabilizing
blood gases and shortening hospital length of stay) in
children with CNSD and moderate to severe mental
retardation presenting to emergency department with
acute respiratory distress due to very severe pneumonia.
Its use speeds stabilization and possibly recover from the
pulmonary affection. The underlying severe neurological
impairment plus the depression of the state of con-
sciousness brought forward by hypercapnia might facili-
tate NIV compliance instead of being an obstacle as
commonly believed.
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